Polyclonal Rabbit anti‑Human CNN2 Antibody (90‑170 aa, Internal, IF, WB) LS‑C382411
Polyclonal Rabbit anti‑Human CNN2 Antibody (90‑170 aa, Internal, IF, WB) LS‑C382411
Antibody:
CNN2 Rabbit anti-Human Polyclonal (90-170 aa, Internal) Antibody
Application:
IF, WB, ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
CNN2 Rabbit anti-Human Polyclonal (90-170 aa, Internal) Antibody
Application:
IF, WB, ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
CNN2 antibody LS-C382411 is an unconjugated rabbit polyclonal antibody to CNN2 (90-170 aa, Internal) from human. It is reactive with human and mouse. Validated for ELISA, IF and WB.
Target
Human CNN2
Synonyms
CNN2 | Calponin 2 | Calponin-2 | Calponin H2, smooth muscle | Neutral calponin
Reactivity
Human, Mouse
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Immunogen
Synthesized peptide derived from human Calponin 2
Epitope
90-170 aa, Internal
Specificity
Calponin 2 Polyclonal Antibody detects endogenous levels of Calponin 2 protein.
Applications
- Immunofluorescence (1:200 - 1:1000)
- Western blot (1:500 - 1:2000)
- ELISA (1:40000)
Presentation
PBS, 0.02% Sodium Azide, 50% Glycerol, 0.5% BSA
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Monkey
Applications:
IHC, IHC - Paraffin, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human, Mouse, Rat, Bovine
Applications:
ICC, Immunofluorescence, Western blot
Source:
E. coli
Tag:
6His, N-terminus
Reactivity:
Human
Range:
0.156-10 ng/ml
Source:
E. coli
Tag:
None
Species:
Human
Applications:
ICC, Immunofluorescence, Peptide Enzyme-Linked Immunosorbent Assay
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 8/14/2024